Glycorex Transplantation AB (publ) is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. The Company’s medical devices enable transplants across the blood groups saving lives and providing health economic benefits by increasing the number of transplants.

• Revenue in SEK (TTM)39.94m
• Net income in SEK-7.06m
• Incorporated1995
• Employees20.00

• Location
  Glycorex Transplantation AB (publ)Scheelevagen 27LUND 223 63SwedenSWE
• Phone+46 462865230
• Fax+46 462865239
• Websitehttps://glycorex.com/